(BENGALURU) (Reuters) – India\u2019s Max Healthcare Institute on Monday reported a 38% rise in its second-quarter profit before tax, as it earned more revenue per bed.<\/p>\n
The hospital and diagnostic services provider\u2019s consolidated profit before tax for the quarter ended Sept. 30 stood at 3.66 billion rupees ($43.99 million) compared with 2.65 billion rupees a year ago.<\/p>\n
Max Healthcare\u2019s average revenue per occupied bed (ARPOB) was 74,600 rupees in the second-quarter, up 13% year-on-year.<\/p>\n
Max Healthcare is the first to report the September-quarter results among its peer hospital chains, with Fortis Healthcare, Apollo Hospitals Enterprise and Aster DM Healthcare due to announce results in the coming days this week.<\/p>\n
Analysts had expected higher occupancy and growth in average revenue per occupied bed for Max Healthcare. The improvement in these operating parameters would also help towards capital allocation for bed capacity expansion, per analysts.<\/p>\n
Valuation (next Estimates (next 12 Analysts\u2019 sentiment<\/p>\n
12 months) months)<\/p>\n
RIC PE EV\/EBITD Revenue Profit Mean # of Stock to<\/p>\n
A growth growth rating* analysts price<\/p>\n
target**<\/p>\n
Max Healthcare 41.05 27.41 25.33 14.03 Buy 14 0.94<\/p>\n
Institute Ltd<\/p>\n
Fortis Healthcare 34.04 18.55 11.51 24.31 Buy 12 0.87<\/p>\n
Ltd<\/p>\n
Apollo Hospitals 53.62 26.22 16.91 39.16 Buy 21 0.93<\/p>\n
Enterprise Ltd<\/p>\n
Aster DM Healthcare 24.86 10.94 11.41 71.93 Buy 6 1.06<\/p>\n
Ltd<\/p>\n
* Mean of analysts\u2019 ratings standardised to a scale of Strong Buy, Buy, Hold, Sell, and Strong Sell<\/p>\n
** Ratio of the stock\u2019s last close to analysts\u2019 mean price target; a ratio above 1 means the stock is trading above the PT<\/p>\n
— All data from LSEG<\/p>\n
— $1 = 83.1927 Indian rupees<\/p>\n